Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 983 of 1,261
  1. US 7825159

    Mixtures of aromatic esters for marking or tagging organic products, marker compositions comprising the same and manufacturing methods thereof

    UNITED COLOR MANUFACTURING, INC. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  2. US 7825231

    Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  3. US 7825150

    Compositions and methods for treating immunological and inflammatory diseases and disorders

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  4. US 7825142

    Heterocyclic compounds, compositions comprising them and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  5. US 7825127

    Method for treating cancer

    Takeda Pharmaceutical Company Limited · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  6. US 7825136

    Potentiators of antibacterial activity

    Vertex Pharmaceuticals Incorporated · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  7. US 7825116

    N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines

    Rigel Pharmaceuticals, Inc. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  8. US 7825096

    O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  9. US 7825242

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  10. US 2010273803

    Oral Formulations for Tetrapyrrole Derivatives

    CERAMOPTEC IND INC [DE] · Granted Oct 28, 2010 · Expires Oct 23, 2030

    granted
  11. US 7820671

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  12. US 7820685

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  13. US 7820631

    Anti-viral pyrimidine nucleoside analogues

    University College Cardiff Consultants Limited · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  14. US 7820162

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Syntonix Pharmaceuticals, Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  15. US 7820663

    Substituted enaminones, their derivatives and uses thereof

    The Regents of the University of California · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  16. US 7820817

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  17. US 7820692

    Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  18. US 7820819

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  19. US 7820447

    Compositions and methods for cancer

    Sagres Discovery, Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  20. US 7820182

    Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  21. US 7820181

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  22. US 7820174

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  23. US 7820784

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  24. US 7820733

    Dental polymerizable core build-up material of separately packed type

    Kuraray Medical Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.